Shandong, China

Guanglian Zhou

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Guanglian Zhou in Pharmaceutical Chemistry

Introduction

Guanglian Zhou is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzimidazole derivatives. His research focuses on developing compounds that have potential therapeutic applications.

Latest Patents

One of Guanglian Zhou's key patents is titled "Benzimidazole derivatives and their pharmaceutical compositions and uses." This invention relates to benzimidazole derivatives of Formula (I), or their stereoisomers, pharmaceutically acceptable salts, or solvates. The patent outlines the preparation methods for these compounds and their use in manufacturing medicaments for the prophylaxis and treatment of peptic ulcers, ulcer hemorrhage, and diseases associated with gastric acid. He holds 1 patent in this area.

Career Highlights

Guanglian Zhou is currently associated with Xuanzhu Pharma Co., Ltd., where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new therapeutic options for patients suffering from gastric-related ailments.

Collaborations

Guanglian Zhou collaborates with various professionals in the field, including his coworker Zhenhua Huang. Their combined expertise contributes to the ongoing research and development efforts at Xuanzhu Pharma Co., Ltd.

Conclusion

Guanglian Zhou's contributions to pharmaceutical chemistry, particularly through his patent on benzimidazole derivatives, highlight his role as an innovator in the field. His work continues to pave the way for new treatments that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…